195 related articles for article (PubMed ID: 35537774)
1. Early renal failure in childhood in a male with Fabry disease.
Hogh JN; Ebrahim H; Moochhala S; Ramaswami U
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35537774
[TBL] [Abstract][Full Text] [Related]
2. Fabry disease with cardiovascular manifestation in a patient with end-stage renal disease.
Skopcová H; Dostálová G; Paleček T; Linhart A; Honsová E
Cesk Patol; 2021; 57(1):49-52. PubMed ID: 33910349
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients.
Doi K; Noiri E; Ishizu T; Negishi K; Suzuki Y; Hamasaki Y; Honda K; Fujita T; Tsukimura T; Togawa T; Saito S; Sakuraba H
J Hum Genet; 2012 Sep; 57(9):575-9. PubMed ID: 22695894
[TBL] [Abstract][Full Text] [Related]
4. Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area.
Zizzo C; Testa A; Colomba P; Postorino M; Natale G; Pini A; Francofonte D; Cammarata G; Scalia S; Sciarrino S; Zoccali C; Duro G
Kidney Blood Press Res; 2018; 43(4):1344-1351. PubMed ID: 30099469
[TBL] [Abstract][Full Text] [Related]
5. Novel GLA T194A variant causes Fabry disease.
Pestana MN; Gomes da Silva F; Durães J; Silva G
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33649041
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.
Chong Y; Kim M; Koh ES; Shin SJ; Kim HS; Chung S
BMC Med Genet; 2016 Oct; 17(1):76. PubMed ID: 27776503
[TBL] [Abstract][Full Text] [Related]
7. Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.
Van Loo A; Vanholder R; Madsen K; Praet M; Kint J; De Paepe A; Messiaen L; Lameire N; Hasholt L; Sørensen SA; Ringoir S
Am J Nephrol; 1996; 16(4):352-7. PubMed ID: 8739292
[TBL] [Abstract][Full Text] [Related]
8. Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease.
Wakakuri H; Nakamura S; Utsumi K; Shimizu W; Yasutake M
Int Heart J; 2016 Sep; 57(5):637-9. PubMed ID: 27593536
[TBL] [Abstract][Full Text] [Related]
9. D313Y variant in two related end-stage renal disease patients - Pathogenic or not yet?
Vicente R; Santos I; Coimbra M; Santos J; Santos R; Amoedo M; Pires C
Nefrologia (Engl Ed); 2023; 43(5):636-639. PubMed ID: 36517364
[TBL] [Abstract][Full Text] [Related]
10. Frequency of Fabry disease in male and female haemodialysis patients in Spain.
Gaspar P; Herrera J; Rodrigues D; Cerezo S; Delgado R; Andrade CF; Forascepi R; Macias J; del Pino MD; Prados MD; de Alegria PR; Torres G; Vidau P; Sá-Miranda MC
BMC Med Genet; 2010 Feb; 11():19. PubMed ID: 20122163
[TBL] [Abstract][Full Text] [Related]
11. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
[TBL] [Abstract][Full Text] [Related]
12. Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.
Oliveira JP; Nowak A; Barbey F; Torres M; Nunes JP; Teixeira-E-Costa F; Carvalho F; Sampaio S; Tavares I; Pereira O; Soares AL; Carmona C; Cardoso MT; Jurca-Simina IE; Spada M; Ferreira S; Germain DP
Eur J Med Genet; 2020 Feb; 63(2):103703. PubMed ID: 31200018
[TBL] [Abstract][Full Text] [Related]
13. De novo mutation in a male patient with Fabry disease: a case report.
Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
[TBL] [Abstract][Full Text] [Related]
14. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
[TBL] [Abstract][Full Text] [Related]
15. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele.
Yasuda M; Shabbeer J; Benson SD; Maire I; Burnett RM; Desnick RJ
Hum Mutat; 2003 Dec; 22(6):486-92. PubMed ID: 14635108
[TBL] [Abstract][Full Text] [Related]
16. Fabry Disease Screening in Patients With Kidney Transplant: A Single-Center Study in Turkey.
Erdogmus S; Kutlay S; Kumru G; Ors Sendogan D; Erturk S; Keven K; Ceylaner G; Sengul S
Exp Clin Transplant; 2020 Aug; 18(4):444-449. PubMed ID: 32281532
[TBL] [Abstract][Full Text] [Related]
17. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
[TBL] [Abstract][Full Text] [Related]
18. Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α-galactosidase A activity: A 14-year follow-up without enzyme replacement therapy.
Odani K; Okumi M; Honda K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():57-9. PubMed ID: 26971403
[TBL] [Abstract][Full Text] [Related]
19. Screening for Fabry disease in male patients with end-stage renal disease in western France.
Vigneau C; Germain DP; Larmet D; Jabbour F; Hourmant M;
Nephrol Ther; 2021 Jun; 17(3):180-184. PubMed ID: 33994139
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease. A case report.
Kotnik J; Kotnik F; Desnick RJ
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):15-9. PubMed ID: 15818441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
